Status:
RECRUITING
A Cohort Study on Biomarkers of Hypertension in Guangdong Province(GDP Study)
Lead Sponsor:
Guangdong Provincial People's Hospital
Conditions:
Hypertension
Cardiovascular Diseases
Eligibility:
All Genders
18+ years
Brief Summary
Hypertension is the most common chronic diseases and a most important risk factor for cardiovascular and cerebrovascular diseases, and also a substantial public health problem. The purpose of the stud...
Detailed Description
Study population includes subjects who are hypertension, of any race or ethnicity, 18 or older years of age, and have provided written informed consent to provide whole blood specimens at one or more ...
Eligibility Criteria
Inclusion Criteria:
- ≥18 years old
- In accordance with the diagnosis of hypertension (including Blood pressure ≥140/90mmHg and/or taking antihypertensive drugs and/or self-reported hypertension)
Exclusion Criteria:
- <18 years old
- Unsigned informed consent
- Pregnant Women and Lactation
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2050
Estimated Enrollment :
50000 Patients enrolled
Trial Details
Trial ID
NCT04212455
Start Date
January 1 2020
End Date
December 31 2050
Last Update
January 13 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, China, 510080
2
Guangdong Cardiovascular Institute
Guangzhou, Guangdong, China, 510100